eMedicine Specialties > Pediatrics: Developmental and Behavioral > Medical Topics

Sleep Disorder, Night Terrors

Author: Kevin P Connelly, DO, Clinical Assistant Professor, Department of Pediatrics, Division of General Pediatrics and Emergency Care, Virginia Commonwealth University; Medical Director, Paws for Health Pet Visitation Program of the Richmond SPCA; Pediatric Emergency Physician, Emergency Consultants Inc, Chippenham Medical Center
Contributor Information and Disclosures

Updated: Dec 8, 2009

Introduction

Background

Sleep disruption is a frequent concern among parents of children aged 2 years or younger. Half of all infants develop a disrupted sleep pattern serious enough to seek physician evaluation.

Night terror disorder is characterized by recurrent episodes of intense crying and fear and by difficulty in waking the child. Children with night terrors often experience signs of autonomic arousal (eg, tachycardia, tachypnea, sweating) during episodes. Children do not recall a dream after a night terror and typically do not remember the episode the next morning. Night terrors are frightening episodes for parents to watch and may cause the child significant distress, fatigue, and impaired daily function. Onset is usually in children aged 4-12 years; the disorder generally spontaneously resolves by adolescence.

Pathophysiology

Sleep is divided into 2 categories: rapid eye movement (REM) and nonrapid eye movement (non-REM). Non-REM sleep is further divided into 4 stages, progressing from stages 1-4. Night terrors occur during the transition from stage 3 non-REM sleep to stage 4 non-REM sleep. Approximately 30-90 minutes after falling asleep, the child enters this light sleep stage and suddenly arises with symptoms of autonomic discharge.

Frequency

United States

An estimated 1-6% of children experience night terror episodes. Recurrent night terror episodes accompanied by significant distress and impairment are less frequent.

Mortality/Morbidity

Most children outgrow night terrors as they mature neurophysiologically.

Race

Children of all races and cultures are affected.

Sex

Males and females are equally affected.

Age

Night terrors are most common among children aged 3-12 years. The median age of onset is 3.5 years. Peak frequency in children younger than 3.5 years is at least one episode per week; among older children, peak frequency is 1-2 episodes per month.1

Clinical

History

The most important step toward diagnosing this disorder is to obtain a detailed history.

  • Approximately 90 minutes after falling asleep, the child sits up in bed and screams. Prominent autonomic activity (eg, tachycardia, tachypnea, diaphoresis, flushing) occurs. The child appears awake but confused, disoriented, and unresponsive to stimuli.
  • Most episodes last 1-2 minutes, but the child may remain inconsolable for 5-30 minutes before relaxing and returning to quiet sleep.
  • If the child awakens during the night terror, only fragmented pieces of the episode may be recalled.
  • In the morning, the child typically has no memory of the experience.

Physical

A complete physical examination is important to exclude other disorders. In general, however, physical examination adds little to information obtained from a complete history.

Causes

  • Episodes of night terrors may be preceded by the following:
    • Stressful life events
    • Fever
    • Sleep deprivation
    • Medications that affect the CNS

More on Sleep Disorder, Night Terrors

Overview: Sleep Disorder, Night Terrors
Differential Diagnoses & Workup: Sleep Disorder, Night Terrors
Treatment & Medication: Sleep Disorder, Night Terrors
Follow-up: Sleep Disorder, Night Terrors
References
[ CLOSE WINDOW ]

References

  1. DiMario FJ Jr, Emery ES 3d. The natural history of night terrors. Clin Pediatr (Phila). Oct 1987;26(10):505-11. [Medline].

  2. Dahl RE. The pharmacologic treatment of sleep disorders. Psychiatr Clin North Am. Mar 1992;15(1):161-78. [Medline].

  3. Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them?. Pediatrics. Jan 2003;111(1):e17-25. [Medline].

  4. Mason TB 2nd, Pack AI. Sleep terrors in childhood. J Pediatr. Sep 2005;147(3):388-92. [Medline].

  5. Pesikoff RB, Davis PC. Treatment of pavor nocturnus and somnambulism in children. Am J Psychiatry. Dec 1971;128(6):778-81. [Medline].

  6. Siegel JM. Why we sleep. Sci Am. Nov 2003;289(5):92-7. [Medline].

  7. Stores G. Aspects of parasomnias in childhood and adolescence. Arch Dis Child. Jan 2009;94(1):63-9. [Medline].

  8. Wise MS. Parasomnias in children. Pediatr Ann. Jul 1997;26(7):427-33. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

night terrors, night-terrors, sleep terrors, night frights, parasomnia, pavor nocturnus, autonomic arousal, sleep disruption, rapid eye movement, REM, nonrapid eye movement, non-REM, tachycardia, diaphoresis, disrupted sleep pattern, night terror disorder, sleep deprivation

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Kevin P Connelly, DO, Clinical Assistant Professor, Department of Pediatrics, Division of General Pediatrics and Emergency Care, Virginia Commonwealth University; Medical Director, Paws for Health Pet Visitation Program of the Richmond SPCA; Pediatric Emergency Physician, Emergency Consultants Inc, Chippenham Medical Center
Kevin P Connelly, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association
Disclosure: Nothing to disclose.

Medical Editor

Chet Johnson, MD, Medical Director, Child Development Unit, Department of Pediatrics, Professor, University of Kansas Medical Center
Chet Johnson, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

Carrie Sylvester, MD, MPH, Director of Education in Child and Adolescent Psychiatry, Professor, Departments of Psychiatry and Pediatrics, Northwestern University Medical School
Carrie Sylvester, MD, MPH is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry, American Academy of Pediatrics, American Medical Women's Association, American Psychiatric Association, and American Society for Adolescent Psychiatry
Disclosure: Nothing to disclose.

Chief Editor

Caroly Pataki, MD, Professor of Clinical Psychiatry and Behavioral Sciences, Department of Psychiatry, Division Chair, Child and Adolescent Psychiatry, Director of Training, Child and Adolescent Psychiatry Residency Program, University of Southern California Keck School of Medicine
Caroly Pataki, MD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry, New York Academy of Sciences, and Physicians for Social Responsibility
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.